...M. Reza Azarpazhooh; Chrysi Bogiatzi; J. David Spence Combining available therapies has the potential to reduce the risk of stroke by 80% or more. A comprehensive review of all aspects of stroke prevention would be very lengthy; in this narrative review, we focus on some aspects of stroke...

...) and the change of national stroke prevention guidelines. Methods: Consecutive patients admitted with an acute cerebrovascular ischemic event underwent regular diagnostic work-up. Pseudonymized clinical data were entered into the institution’s stroke registry. In those patients with AF, discharge letters were...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Stroke prevention Pathophysiology Epidemiology Air masses Weather...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Stroke epidemiology Stroke in developing countries Stroke prevention...

... hemorrhage hemorrhage associated with oral anticoagulation LAA closure Stroke prevention Percutaneous left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulation for stroke prevention in atrial fibrillation (AF) [ 1 ]. This approach has been proposed in patients with a higher...

... analyses. Methods: We subtyped IIS into definite, possible and noncardioembolic using the Stroke Prevention in Atrial Fibrillation method. Statistical tests, stratified by prior ischemic stroke or transient ischemic attack, were the conditional binomial for independent Poisson variables for rates...

...Kazunori Toyoda; Thorsten Steiner; Corina Epple; Rolf Kern; Masao Nagayama; Yukito Shinohara; Michael G. Hennerici Background: Different aspects of acute stroke management and strategies for stroke prevention derive from two viewpoints: specific traditional and historical backgrounds and evidence...

...Rolf Kern; Masao Nagayama; Kazunori Toyoda; Thorsten Steiner; Michael G. Hennerici; Yukito Shinohara Background: Different aspects of acute stroke management and strategies for stroke prevention derive from two viewpoints: specific traditional and historical backgrounds and evidence-based medicine...

... be further expanded as the oral factor Xa inhibitor apixaban has shown promise in its recent phase 3 trial and is under consideration for FDA approval. Nonpharmacologic approaches to stroke prevention in AF are under development as well. These approaches focus on occlusion or ligation of the left atrial...

.... References 1. Galimanis A, Mono A-L, Arnold M, Nedeltchev K, Mattle HP: Lifestyle and stroke risk: a review. Curr Opin Neurol 2009;22:60–68. 2. Fisher M, Lees K, Spence JD: Nutrition and stroke prevention. Stroke 2006;37:2430–2435. 3. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Aspirin Stroke prevention Short Report Ccrebrovasc Dis 1995;5:308-309 M.G. Hennerici Neurologische Klinik der Universität zu Heidelberg, Klinikum Mannheim, Mannheim...

.... Atrial fibrillation Stroke prevention Anticoagulation National Institutes of Health (NIH) 10.13039/100000002 All cases were assessed by a trained study physician, with in-person assessment performed by an experienced stroke physician where there was a query over the diagnosis...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antithrombotic therapy Stroke prevention Antiplatelet drugs Oral anticoagulants Cerebrovasc Dis 2009;27(suppl 3):12 19 DOI: 10.1159/000209261 Published online: May 14...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antiplatelet therapy Aspirin Dementia Ischemic stroke PERFORM Study Transient ischemic attack Terutroban TP receptor antagonist Stroke...

... treatment Stenting Carotid artery stenosis Randomised trial Stroke prevention © 2009 S. Karger AG, Basel 2009 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any...

... antagonist Stroke prevention Ischemic stroke accounts for approximately 87% of all strokes and is the second largest cause of mortality worldwide [ 1, 2 ]. Major advances in the prevention of recurrent ischemic stroke have occurred over the past 30 years, and current strategies include...

.... Antiplatelet therapy Aspirin Dementia Ischemic stroke PERFORM Study Transient ischemic attack Terutroban TP receptor antagonist Stroke prevention Stroke is the leading cause of death worldwide [ 1, 2 ], and a major cause of acquired disability. By contrast with the declining incidence...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Stroke prevention Edaravone Ozagrel Antiplatelet agent Stroke...

... the effect of cilostazol, an antiplatelet agent, in these high-risk subjects. Methods: A post hoc subgroup analysis of the already reported Cilostazol Stroke Prevention Study, which was a placebo-controlled double-blind trial, has been carried out to clarify the influence of various complications...

..., instructions or products referred to in the content or advertisements. Stroke prevention Educational measures Stroke Unit Imaging Acute treatment Rehabilitation This article represents the update of the European Stroke Initiative (EUSI) Recommendations for Stroke Management, which were first...